BTSG Earnings Date: Feb 26, 2027 (Estimated) — BrightSpring Health Services, Inc. Common Stock
NASDAQ · Healthcare · Health Information Services
Updated
When is BTSG's next earnings date?
BrightSpring Health Services, Inc. Common Stock (BTSG) is expected to report Q4 2026 earnings on Friday, February 26, 2027 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.52 on revenue of $4.02B.
How did BTSG do in its last earnings report?
In its most recent report on Oct 30, 2026, BrightSpring Health Services, Inc. Common Stock posted EPS of $0.54 versus the $0.47 estimate, a beat of 14.2%. Revenue was $4.21B against a $3.88B estimate.
How much does BTSG stock move after earnings?
BTSG beat EPS estimates in 5 of its last 8 reported quarters. Over the last 7 reports the stock moved an average of 8.2% (up or down) in the day after earnings.
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
🤖 AI Earnings Analysis
BrightSpring’s Q3 beat and raised 2026 guidance make for a strong update, though 1,459% revenue growth likely reflects a distorted comparison and 1.5% margins leave limited room for execution missteps. EPS was $0.54 versus $0.47 expected.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-30 | 0.47 | 0.54 | +14.21% | $4.21B | ✅ Beat | — | — | — | |
| 2026-07-31 | Q2 2026 | 0.38 | 0.45 | +18.42% | $3.87B | ✅ Beat | -18.07% | -16.85% | -18.87% |
| 2026-05-01 | Q1 2026 | 0.31 | 0.39 | +25.81% | $3.61B | ✅ Beat | +9.61% | +10.36% | +25.04% |
| 2026-02-27 | Q4 2025 | 0.34 | 0.33 | -2.94% | $3.55B | ❌ Miss | +3.24% | +4.09% | +5.48% |
| 2025-10-28 | Q3 2025 | 0.33 | 0.30 | -9.09% | $3.33B | ❌ Miss | +0.15% | -5.79% | +7.29% |
| 2025-08-01 | Q2 2025 | 0.19 | 0.22 | +15.79% | $3.15B | ✅ Beat | -4.89% | -0.92% | +14.72% |
| 2025-03-06 | Q4 2024 | 0.21 | 0.22 | +4.76% | $3.05B | ✅ Beat | -6.31% | -3.43% | -3.32% |
| 2024-11-01 | Q3 2024 | 0.17 | 0.11 | -35.29% | $2.91B | ❌ Miss | +15.23% | +26.39% | +27.45% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $1.73B total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Commercial Insurance | 72.1% | $1.25B | +43.2% | $718.0M | $786.1M | $869.6M | $1.65B |
| Medicaid | 27.9% | $482.2M | +16.0% | $577.5M | $354.7M | $415.7M | $724.8M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.